Pharma Pulse 6/11/24: How Moderna is Implementing AI and ChatGPT, Managing Palliative Care Challenges for Patients with Complex Symptoms & more


The latest news for pharma industry insiders.

How Moderna is Implementing AI and ChatGPT

In this part of his Pharmaceutical Executive video interview, Brice Challamel, Vice President, AI Products & Platforms, Moderna, discusses how AI, specifically GPTs, have had a significant impact on Moderna's mission.

Managing Palliative Care Challenges for Patients with Complex Symptoms

In an interview with the Pharmacy Times, Justin Kullgren, PharmD, FAAHPM, Palliative Medicine Clinical Pharmacist Specialist and PGY2 Pain Management & Palliative Care Residency Program Director at The Ohio State University Wexner Medical Center, James Cancer Hospital, shares insights into palliative care and common challenges faced by pharmacists treating patients with complicated symptoms.

Operational Oversight in Clinical Research: Integrations and Insights

A recent IQVIA survey revealed that one-third of sponsors fully or partially outsource their clinical trials to several service providers (i.e., CROs, etc.). Although this model usually results in the successful execution of trials, it also creates numerous challenges. For example, sponsor’s data resides with different providers and reports and metrics are produced at varying frequencies and provided in different formats and nomenclatures. This requires sponsors to spend too much time wrangling data from all trials across their portfolio and manually processing reports to maintain the necessary, and ICH E6 required, level of operational oversight.

Join this webinar to learn how IQVIA Technologies Clinical Data Analytics Solutions (CDAS) offers sponsors an answer to the challenge of high quality, timely oversight in an outsourced clinical trial model. CDAS provides powerful analytics capabilities and a robust library of standard dashboards and reports, while also enabling the flexibility of self-service reporting and the power of generative AI to question data directly. Acquiring and standardizing data from multiple sources to support the required analytics is driven by multiple easy-to-use ingestion adaptors and the ability to harmonize data to a comprehensive common operational data model, providing the data foundation for cross-study and portfolio-level standardized analytics and reporting for sponsors. Data integration and harmonization services are also available to complement the offering, thus requiring minimal involvement from internal teams to prepare data, saving time and energy to focus on timely, proactive oversight activities.

CrowdStrike Chief, FBI Agent and Others Discuss Spies, Threats and Deepfakes, at WSJ Tech Live: Cybersecurity

Event looked at national security, ‘pig-butchering’ scams and AI.

Health for Mankind Company Launches DIABIMETRICS

Health for Mankind Company, a digital health startup, announces the introduction of DIABIMETRICS™, a digital health platform designed to revolutionize diabetes management with a focus on historically underserved communities. This significant tool is available through Google play with Apple’s App store coming online shortly.

Blue Fin Group, an IntegriChain Company on LinkedIn:

Don't miss William Roth's thought-provoking series, Who Moved My Prescription?

Part 4 in thePharmaceutical Commerce Magazine:
Who Moved My Prescription? Part 3:
Who Moved My Prescription? Part 2:
Who Moved My Prescription? Part 1:

Have news you want us to share in Pharma Pulse? Reach out to Social Media Editor Miranda Schmalfuhs

© 2024 MJH Life Sciences

All rights reserved.